[1] PRATIC?魹 A D,FALSAPERLA R,RIZZO R,et al. A new patient with Potocki-Lupski syndrome:a literature review[J]. J Pediatr Genet,2018,7(1):29-34.
[2] POTOCKI L,BI W,TREADWELL-DEERING D,et al. Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype[J]. Am J Hum Genet,2007,80(4):633-649.
[3] 中华医学会医学遗传学分会遗传病临床实践指南撰写组. Noonan综合征的临床实践指南[J]. 中华医学遗传学杂志,2020,37(3):324-328.
[4] FRANCISKOVICH R,SOLER-ALFONSO C,NEIRA-FRESNEDA J,et al. Short stature and growth hormone deficiency in a subset of patients with Potocki-Lupski syndrome:expanding the phenotype of PTLS[J]. Am J Med Genet A,2020,182(9):2077-2084.
[5] 李辉,宗心南,张亚钦.中国七岁以下儿童体重、身长/身高和头围的生长标准值及标准化生长曲线[J]. 中华儿科杂志,2009,47(3):173-178
[6] MAGOULAS P L,LIU P,GELOWANI V,et al. Inherited dup(17)(p11.2p11.2):expanding the phenotype of the Potocki-Lupski syndrome[J]. Am J Med Genet A,2014,164A(2):500-504.
[7] 王荣跃,雷婷缨,符芳,等. 染色体微阵列分析技术在489例生长发育迟缓/智力低下患儿中的应用[J]. 中华医学遗传学杂志,2017,34(4):528-533.
[8] ZHANG F,POTOCKI L,SAMPSON J B,et al. Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS[J]. Am J Hum Genet,2010,86(3):462-470.
[9] CIACCIO C,PANTALEONI C,MILANI D,et al. Neurological phenotype of Potocki-Lupski syndrome[J]. Am J Med Genet A,2020,182(10):2317-2324.
[10] NEIRA-FRESNEDA J,POTOCKI L. Neurodevelopmental disorders associated with abnormal gene dosage:smith-magenis and Potocki-Lupski syndromes[J]. J Pediatr Genet,2015,4(3):159-167.
[11] CARMONA-MORA P,WALZ K. Retinoic acid induced 1,RAI1:adosage sensitive gene related to neurobehavioral alterations including autistic behavior[J]. Curr Genomics,2010,11(8):607-617.